RE: Avacta1 Jun 2021 17:22
Mologic have at least 3 antigen lfts in development. The one being fast tracked in the States is our's, the one they are partnering with Avacta on and one with the Aptamer Group. Check out their website.
They stated it was Mologic's job to apply for Avacta's registration. And that Mologic delegated that role. Then they commented on a social media allegation (!) to say, not us, Mologic! It's definitely vs the law. The MHRA responded to an FOI request on 7th May, asking if they have turned down any vaccines or treatments and they cited section 43 of the FOI which precludes them from commenting on commercially sensitive data.
So they haven't told Avacta that one of Mologic's tests have been turned down if it's true.
Imo they can see that Mologic are off to the races in Europe with 2 registrations (already in line for EU certification) and the US with the fast track approval though NIH and they are trying to undermine them.
Playing dirty.
Avacta will end up with no manufacturing partner at this rate. If they ever get a test approved. Why do their shareholders think they don't need proper approval? Absolutely bizarre!